Source of Regulatory status by jurisdiction

{{Infobox concept | name = Regulatory status by jurisdiction | subtitle = Regulation and law | Determined by = Regulatory category, not chemical identity | Categories = Medicine, research reagent, controlled substance, unregulated | Consequence = The same molecule differs in status between countries }} {{cleanup|talk=Structure of the jurisdiction material}} '''Regulatory status by jurisdiction''' describes how the legal treatment of a substance differs between countries. Status follows from the regulatory category a substance occupies in a given jurisdiction, and the same molecule may be a licensed medicine in one, an unapproved investigational compound in another, and a research reagent in a third.{{r|wco}} Category is not a property of the chemistry. It follows from whether a marketing authorisation exists, what the substance is presented for, and whether it appears on any scheduling list.{{r|fda_pip}} This article describes the structure of the question. It does not state the law of any jurisdiction, does not advise on legality, and should not be relied on for either.{{r|ich_q7}} == The categories == | Category | Typical consequence | |---|---| | Authorised medicine | Prescription and distribution rules apply | | Unapproved investigational compound | Not lawfully supplied as a medicine | | Research reagent | Supplied for laboratory use; not for administration | | Controlled substance | Scheduling rules; possession may be an offence | | Unregulated | Ordinary commercial law only | Most peptides discussed on this wiki sit in the second or third category in most jurisdictions. The [[Research use only]] designation is a statement of the third and is a presentation as much as a status: the same material presented as a medicine is a medicine.{{r|usp1503}} The presentation test is the mechanism by which many jurisdictions treat a product: claims made about a substance can bring it within medicines law regardless of what the label says elsewhere.{{r|fda_pip}} == Why status differs == Marketing authorisations are granted jurisdiction by jurisdiction, so a molecule approved in one country is unapproved in another until an application succeeds there. Approval timing therefore produces genuine differences in status for identical material.{{r|fda_pip}} Scheduling decisions are made nationally and reflect local policy. Substances prohibited in sport under anti-doping rules are subject to a separate regime again, which is contractual rather than legal in most cases.{{r|wco}} Sub-national variation exists in federal systems, particularly for compounding and dispensing, which is why [[503A compounding pharmacy|compounding]] rules cannot be summarised at national level alone.{{r|ich_q7}} == What this means practically == A statement that a substance is "legal" is incomplete without a jurisdiction, a category and a purpose. The same three questions apply to any claim encountered in supplier material.{{r|reports}} Border treatment follows from status but is not identical to it, since enforcement discretion and declaration also operate. See [[Customs seizure]] and [[Personal importation policy]].{{r|fda_pip}} This wiki sells nothing, is independent of every organisation named in it, and gives no legal advice. Research-use compounds are not approved for human administration.{{r|usp1503}} == References == {{reflist}} <ref name="wco">World Customs Organization, ''International Convention on the Simplification and Harmonization of Customs Procedures'' (revised Kyoto Convention).</ref> <ref name="fda_pip">United States Food and Drug Administration, ''Regulatory Procedures Manual'', chapter 9 (coverage of personal importations).</ref> <ref name="ich_q7">International Council for Harmonisation, ''Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients'' (2000).</ref> <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> <ref name="reports">PeptidePedia Wiki community test-report tally, 2024–2026 (self-reported; see [[Project:Sourcing_guidelines]]).</ref> == See also == * [[Personal importation policy]] * [[Customs seizure]] * [[Research use only]] * [[Grey market]] * [[503A compounding pharmacy]] {{DEFAULTSORT:Regulatory status by jurisdiction}} [[Category:Legal status by jurisdiction]] [[Category:Regulation and law]] [[Category:Articles needing cleanup]]